He is the chairman and chief executive officer (CEO) of Johnson & Johnson, an American multinational conglomerate. [1] He is the company's eighth CEO since it became a publicly-traded company in 1944. In 2023, Duato received $28.4 million, the highest paid CEO of any major US pharmaceutical company.

Joaquin Duato is Chairman and Chief Executive Officer of Johnson & Johnson. Under his leadership, J&J is now exclusively focused on tackling the toughest health challenges by developing innovative medicines and medtech solutions.

Joaquin Duato is Chairman and Chief Executive Officer of Johnson & Johnson. Under his leadership, J&J is now exclusively focused on tackling the toughest health challenges by developing innovative medicines and medtech solutions.

2022年3月21日 · Meet Johnson & Johnson’s new CEO Joaquin Duato and learn about his leadership lessons and his commitment to improving global health by putting patients first.

2022年3月23日 · 今年1月，杜安卿(Joaquin Duato)履新成为强生公司的首席执行官(CEO)。 杜安卿在强生公司已经打拼了33年，在全球不同国家和地区和公司各大业务板块累积了丰富的经验。

Joaquin Duato was appointed the eighth CEO of Johnson & Johnson. He began his career with the company in 1989 in Madrid, Spain and earned positions of increasing global responsibility, which included leading the company’s global pharmaceutical business and in 2018, becoming vice chairman of the Johnson & Johnson Executive Committee.

2025年2月2日 · Duato, who has been CEO since 2022 and chairman since 2023, says the company's current level of investment is aimed at shifting its portfolio “to address unmet needs in high-growth,...

2021年8月19日 · Joaquin Duato will become Johnson & Johnson's new CEO effective Jan. 3, replacing Alex Gorsky. Duato will also be appointed as a member of the company's board of …

2022年1月、ホアキン・デュアトがジョンソン・エンド・ジョンソンの新しい最高経営責任者（ceo）に就任しました。 デュアトは過去33年間にわたり、世界各国のジョンソン・エンド・ジョンソンで勤務し、ほぼすべてのビジネス部門に従事した経験を持ちます。